Metabolic differences between hearts of patients with aortic valve disease and hearts of patients with ischaemic disease

Journal of Molecular and Cellular Cardiology

Volumn 30, Issue 11, 1998, Pages 2519-2523

  Suleiman, M S ^a   Caputo, M ^a   Ascione, R ^a   Bryan, A J ^a   Lucchetti, V ^a   Gomes, W J ^a   Angelini, G D ^a  

^a UNIVERSITY OF BRISTOL   (United Kingdom)

Author keywords

Adenine nucleotides; Amino acids; Hypertrophy; Ischaemia; Lactate; Metabolism

Indexed keywords

ADENINE NUCLEOTIDE; ADENOSINE DIPHOSPHATE; ADENOSINE TRIPHOSPHATE; ALANINE; AMINO ACID; LACTIC ACID;

AORTA VALVE DISEASE; ARTICLE; CLINICAL ARTICLE; ENERGY METABOLISM; FEMALE; HEART MUSCLE BIOPSY; HEART MUSCLE METABOLISM; HUMAN; HUMAN TISSUE; ISCHEMIC HEART DISEASE; MALE; PRIORITY JOURNAL; PROTEIN METABOLISM;

EID: 0032213821     PISSN: 00222828     EISSN: None     Source Type: Journal    
DOI: 10.1006/jmcc.1998.0814     Document Type: Article

References (16)

1. BUCKBERG GC, 1995. Update on current techniques of myocardial protection. Ann Thorac sug 60: 805-814.
2. CHUA B, KAO RL, RANNELES DE, MORGAN HE, 1979. Inhibition of protein degradation by anoxia and ischemia in perfused rat hearts. J Biol Chem 254: 6617-6623.
3. CHUA BHL, 1994. Specificity of leucine effect on protein degradation in perfused rat heart. J Mol Cell Cardiol 26: 743-751.
4. 31P magnetic resonance spectroscopy. Lancet 338: 973-976.
5. DORMAN BH, HEBBAR L, CLAIR MJ, HINTON RB, ROY RC, SPINALE FG, 1997. Potassium channel opener augmented cardioplegia-protection of myocyte contractility with chronic left ventricular dysfunction. Circulation 96: 253-259.
6. HILDEBRANDT EF, BUXTON DB, OLSON MS, 1988. Acute regulation of the branched-chain 2-oxo acid dehydrogenase complex by adrenaline and glucagon in the perfused rat heart. Biochem J 250: 835-841.
7. HUXTABLE R, BRESSLER R, 1974. Taurine concentration in congestive heart failure. Science 184: 1187-1188.
8. JI LL, FU RG, MITCHELL EW, GRIFFITHS M, WALDROP TG, SWARTZ HM, 1994. cardiac hypertrophy alters myocardial response to ischemia and reperfusion in vivo. Acta Physiol Scand 151: 279-290.
9. MCAINSH AM, TURNER MA, OHARE D, NITHYTHYANANTHAN R, JOHNSTON DG, OGORMAN DJ, SHERIDAN DJ, 1995. Cardiac hypertrophy impairs recovery from ischemia because there is a reduced reactive hyperaemic response. Cardiovasc Res 30: 113-121.
10. NEUBAUER S, HORN M, PABST T, HARRE K, STROMER H, BERTSCH G, SANDSTEDE J, ERTL G, HAHN D, KOCHSIEK K, 1997. Cardiac high-energy phosphare metabolism in patients with aortic disease assessed by P31 magnetic resonance spectroscopy. J Invest Med 45: 453-462.
11. ROSSI A, LORTET S, 1996. Energy metabolism patterns in mammalian myocardium adapted to chronic physiopathological conditions. Cardiovasc Res 31: 163-171.
12. SCHONEKESS BO, ALLARD MF, LOPASCHUK GD, 1996. Recovery of glycolysis and oxidative metabolism during postischemic reperfusion of hypertrophied rat heart. Am J Physiol 40: H798-H805.
13. SULEIMAN M-S, BIRKETT S, WALLACE D, ANGELINI GD, 1996. Changes in the free intracellular amino acid pool in human saphenous vein organ culture. Experimental Physiol 81: 435-446.
14. SULEIMAN M-S, DIHMIS WC, CAPUTO M, ANGELINI GD, BRYAN AJ, 1997. Changes in the intracellular concentration of glutamate and aspartate in hearts of patients undergoing coronary artery surgery. Am J Physiol 272: H1063-H1069.
15. TAEGTMEYER H, 1994. Energy metabolism of the heart: from basic concepts to clinical applications. Current Problems in Cardiology 19: 62-113.
16. ZHANG YD, XU SC, 1995. Increased vulnerability of hypertrophied myocardium to ischemia and reperfusion injury: relation to cardiac renin-angiotensin system. Chinese Med J 108: 28-32.